Ebola vaccination

Felicity Fitzgerald¹, Shunmay Yeung², Diana M Gibb³, David E Baion⁴, Andrew Pollard⁵

Affiliations

¹ Infection, Immunity, Inflammation and Physiological Medicine, Institute of Child Health, University College London, London WC1N 1EH, UK; Kerry Town Ebola Treatment Centre, Save the Children International, Kerry Town, Sierra Leone. Electronic address: felicity.fitzgerald@ucl.ac.uk.
² Department of Global Health and Development and Department of Clinical Research, London School of Hygiene & Tropical Medicine, London, UK.
³ Medical Research Centre, University College London, London WC1N 1EH, UK.
⁴ Ola During Children's Hospital, Ministry of Health, Freetown, Sierra Leone.
⁵ Oxford Vaccine Group, University of Oxford, Oxford, UK.

PMID: 26738714
DOI: 10.1016/S0140-6736(15)01243-X

Comment

Ebola vaccination

Felicity Fitzgerald et al. Lancet. 2015.

. 2015 Dec 19;386(10012):2478.

doi: 10.1016/S0140-6736(15)01243-X. Epub 2015 Dec 18.

Authors

Felicity Fitzgerald¹, Shunmay Yeung², Diana M Gibb³, David E Baion⁴, Andrew Pollard⁵

Affiliations

¹ Infection, Immunity, Inflammation and Physiological Medicine, Institute of Child Health, University College London, London WC1N 1EH, UK; Kerry Town Ebola Treatment Centre, Save the Children International, Kerry Town, Sierra Leone. Electronic address: felicity.fitzgerald@ucl.ac.uk.
² Department of Global Health and Development and Department of Clinical Research, London School of Hygiene & Tropical Medicine, London, UK.
³ Medical Research Centre, University College London, London WC1N 1EH, UK.
⁴ Ola During Children's Hospital, Ministry of Health, Freetown, Sierra Leone.
⁵ Oxford Vaccine Group, University of Oxford, Oxford, UK.

PMID: 26738714
DOI: 10.1016/S0140-6736(15)01243-X

No abstract available

PubMed Disclaimer

Comment in

Ebola vaccination - Authors' reply.
Longini IM, Egger M, Dean NE, Edmunds WJ, Henao-Restrepo AM; study steering group. Longini IM, et al. Lancet. 2015 Dec 19;386(10012):2480. doi: 10.1016/S0140-6736(15)00951-4. Epub 2015 Dec 18. Lancet. 2015. PMID: 26738716 No abstract available.

Comment on

Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial.
Henao-Restrepo AM, Longini IM, Egger M, Dean NE, Edmunds WJ, Camacho A, Carroll MW, Doumbia M, Draguez B, Duraffour S, Enwere G, Grais R, Gunther S, Hossmann S, Kondé MK, Kone S, Kuisma E, Levine MM, Mandal S, Norheim G, Riveros X, Soumah A, Trelle S, Vicari AS, Watson CH, Kéïta S, Kieny MP, Røttingen JA. Henao-Restrepo AM, et al. Lancet. 2015 Aug 29;386(9996):857-66. doi: 10.1016/S0140-6736(15)61117-5. Epub 2015 Aug 3. Lancet. 2015. PMID: 26248676 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

Substances

Actions

Grants and funding

MR/K023535/1/MRC_/Medical Research Council/United Kingdom

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Medical
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Ebola vaccination

Affiliations

Ebola vaccination

Authors

Affiliations

Comment in

Comment on

Publication types

MeSH terms

Substances

Grants and funding

LinkOut - more resources

Full Text Sources

Medical